Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study.

Mooijaart SP, Sattar N, Trompet S, Lucke J, Stott DJ, Ford I, Jukema JW, Westendorp RG, de Craen AJ; PROSPER Study Group.

J Intern Med. 2013 Jul;274(1):77-85. doi: 10.1111/joim.12052. Epub 2013 Mar 11.

2.

C-reactive protein and genetic variants and cognitive decline in old age: the PROSPER study.

Mooijaart SP, Sattar N, Trompet S, Polisecki E, de Craen AJ, Schaefer EJ, Jahn SE, van Himbergen T, Welsh P, Ford I, Stott DJ, Westendorp RG; PROSPER Study Group.

PLoS One. 2011;6(9):e23890. doi: 10.1371/journal.pone.0023890. Epub 2011 Sep 7.

3.

Systemic markers of inflammation and cognitive decline in old age.

Schram MT, Euser SM, de Craen AJ, Witteman JC, Frölich M, Hofman A, Jolles J, Breteler MM, Westendorp RG.

J Am Geriatr Soc. 2007 May;55(5):708-16.

PMID:
17493190
4.

Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study.

Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Jukema JW, Westendorp RG; PROSPER Group.

Brain. 2008 Apr;131(Pt 4):1069-77. doi: 10.1093/brain/awn023. Epub 2008 Feb 26.

PMID:
18304957
5.

Association between apolipoprotein E4 and cognitive decline in elderly adults.

Packard CJ, Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group.

J Am Geriatr Soc. 2007 Nov;55(11):1777-85.

PMID:
17979899
6.

Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers.

Marsland AL, Petersen KL, Sathanoori R, Muldoon MF, Neumann SA, Ryan C, Flory JD, Manuck SB.

Psychosom Med. 2006 Nov-Dec;68(6):895-903.

PMID:
17132839
7.

In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease.

Jenny NS, Tracy RP, Ogg MS, Luong le A, Kuller LH, Arnold AM, Sharrett AR, Humphries SE.

Arterioscler Thromb Vasc Biol. 2002 Dec 1;22(12):2066-71.

8.

Genetic variation in galectin-3 gene associates with cognitive function at old age.

Trompet S, Jukema W, Mooijaart SP, Ford I, Stott DJ, Westendorp RG, de Craen AJ.

Neurobiol Aging. 2012 Sep;33(9):2232.e1-2232.e9. doi: 10.1016/j.neurobiolaging.2012.05.001. Epub 2012 Jun 5.

9.

Temporal relationship between handgrip strength and cognitive performance in oldest old people.

Taekema DG, Ling CH, Kurrle SE, Cameron ID, Meskers CG, Blauw GJ, Westendorp RG, de Craen AJ, Maier AB.

Age Ageing. 2012 Jul;41(4):506-12. doi: 10.1093/ageing/afs013. Epub 2012 Feb 27.

PMID:
22374646
10.

Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging.

Weaver JD, Huang MH, Albert M, Harris T, Rowe JW, Seeman TE.

Neurology. 2002 Aug 13;59(3):371-8.

PMID:
12177370
11.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
12.

Pravastatin and cognitive function in the elderly. Results of the PROSPER study.

Trompet S, van Vliet P, de Craen AJ, Jolles J, Buckley BM, Murphy MB, Ford I, Macfarlane PW, Sattar N, Packard CJ, Stott DJ, Shepherd J, Bollen EL, Blauw GJ, Jukema JW, Westendorp RG.

J Neurol. 2010 Jan;257(1):85-90. doi: 10.1007/s00415-009-5271-7. Epub 2009 Aug 4.

PMID:
19653027
13.
14.

Lipid lowering agents, cognitive decline, and dementia: the three-city study.

Ancelin ML, Carrière I, Barberger-Gateau P, Auriacombe S, Rouaud O, Fourlanos S, Berr C, Dupuy AM, Ritchie K.

J Alzheimers Dis. 2012;30(3):629-37. doi: 10.3233/JAD-2012-120064.

15.

Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women.

Ryan J, Carrière I, Amieva H, Rouaud O, Berr C, Ritchie K, Scarabin PY, Ancelin ML.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1763-8. doi: 10.1016/j.euroneuro.2013.06.003. Epub 2013 Aug 7.

16.

Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins.

Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, Schellenberg GD.

Neurology. 1998 Jun;50(6):1580-5.

PMID:
9633697
17.

Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study.

Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FG.

Psychosom Med. 2007 Jun;69(5):425-34. Epub 2007 Jun 7.

PMID:
17556639
18.

Cardiovascular risk factors and cognitive decline in adults aged 50 and over: a population-based cohort study.

Dregan A, Stewart R, Gulliford MC.

Age Ageing. 2013 May;42(3):338-45. doi: 10.1093/ageing/afs166. Epub 2012 Nov 25.

PMID:
23179255
19.

Genetic priming of a proinflammatory profile predicts low IQ in octogenarians.

Krabbe KS, Mortensen EL, Avlund K, Pilegaard H, Christiansen L, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H.

Neurobiol Aging. 2009 May;30(5):769-81. Epub 2007 Oct 25.

PMID:
17913303
20.

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.

van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J.

Neurology. 2010 Sep 14;75(11):997-1002. doi: 10.1212/WNL.0b013e3181f25f06.

PMID:
20837967

Supplemental Content

Support Center